Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics

Detalhes bibliográficos
Autor(a) principal: Sharifi-Rad, M
Data de Publicação: 2020
Outros Autores: Lankatillake, C, Dias, DA, Docea, AO, Mahomoodally, MF, Lobine, D, Chazot, PL, Kurt, B, Tumer, TB, Moreira, AC, Sharopov, F, Martorell, M, Martins, N, Cho, WC, Calina, D, Sharifi-Rad, J
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/145264
Resumo: Among the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article review the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs.
id RCAP_aff45c4443a03078f052978387b6f0dd
oai_identifier_str oai:repositorio-aberto.up.pt:10216/145264
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeuticsAlzheimer’s diseaseDementiasNatural compoundsNeurodegenerative disordersParkinson’s diseasePharmacological activitiesPlants secondary metabolitesAmong the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article review the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs.MDPI20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/145264eng2077-038310.3390/jcm9041061Sharifi-Rad, MLankatillake, CDias, DADocea, AOMahomoodally, MFLobine, DChazot, PLKurt, BTumer, TBMoreira, ACSharopov, FMartorell, MMartins, NCho, WCCalina, DSharifi-Rad, Jinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T16:14:11Zoai:repositorio-aberto.up.pt:10216/145264Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:39:34.779469Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
title Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
spellingShingle Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
Sharifi-Rad, M
Alzheimer’s disease
Dementias
Natural compounds
Neurodegenerative disorders
Parkinson’s disease
Pharmacological activities
Plants secondary metabolites
title_short Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
title_full Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
title_fullStr Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
title_full_unstemmed Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
title_sort Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics
author Sharifi-Rad, M
author_facet Sharifi-Rad, M
Lankatillake, C
Dias, DA
Docea, AO
Mahomoodally, MF
Lobine, D
Chazot, PL
Kurt, B
Tumer, TB
Moreira, AC
Sharopov, F
Martorell, M
Martins, N
Cho, WC
Calina, D
Sharifi-Rad, J
author_role author
author2 Lankatillake, C
Dias, DA
Docea, AO
Mahomoodally, MF
Lobine, D
Chazot, PL
Kurt, B
Tumer, TB
Moreira, AC
Sharopov, F
Martorell, M
Martins, N
Cho, WC
Calina, D
Sharifi-Rad, J
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sharifi-Rad, M
Lankatillake, C
Dias, DA
Docea, AO
Mahomoodally, MF
Lobine, D
Chazot, PL
Kurt, B
Tumer, TB
Moreira, AC
Sharopov, F
Martorell, M
Martins, N
Cho, WC
Calina, D
Sharifi-Rad, J
dc.subject.por.fl_str_mv Alzheimer’s disease
Dementias
Natural compounds
Neurodegenerative disorders
Parkinson’s disease
Pharmacological activities
Plants secondary metabolites
topic Alzheimer’s disease
Dementias
Natural compounds
Neurodegenerative disorders
Parkinson’s disease
Pharmacological activities
Plants secondary metabolites
description Among the major neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article review the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/145264
url https://hdl.handle.net/10216/145264
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2077-0383
10.3390/jcm9041061
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136301858947072